eClinical Software: October 2008
The latest eClinical software in the clinical trials industry.
Send your new product info to: Kerri Nelen, knelen@advanstar.com
EDC Management and Reporting Adds Features
New enhancement expands Rave's EDC data-reporting capabilities
Medidata Solutions (New York, NY) introduced its latest enhancement to the company's Medidata Rave EDC management and reporting system.The Dynamic Tabulation Engine expands Rave's data-reporting capabilities to increase data availability and ease of use.
Rave's Dynamic Tabulation Engine
The Dynamic Tabulation Engine employs an interface that allows users to define how clinical data sets and tables are collated, formatted, and extracted. Clinical data can then be immediately viewed, extracted to an external data warehouse or processed by third-party reporting and analysis tools.
Once defined, tabulation formats can be reused across studies in Rave, to streamline data extraction and ensure consistency across studies.
Medidata, (888) 703-1122, www.mdsol.com
Web-based Solution for Trial Site Recruitment
Solution to speed up site and investigator selection
Health Market Science (HMS; King of Prussia, PA) announced its Clinical Investigators, a Web-based software service for pharmaceutical company and CRO clinical trial site recruitment.
Health Market Science Clinical Investigators
Clinical Investigators links an intuitive Web-based user interface with a national, comprehensive database of trial experience detail, claims data, and the HMS Provider Master File. The database features over 4.5 million individual providers, and 1 million health care organizations.
The database includes physician reference data, clinical trial experience, and claims volume rankings, which can help accelerate, identify, and recruit investigators with access to the patients needed for a particular trial.
Health Market Science, (800) 593-4467, www.healthmarketscience.com
CTMS Works with Microsoft Office
Software based on Microsoft office eliminates incompatible apps
TranSenda International (Bellevue, WA) announced Office Smart Clinical Trial Manager, a clinical trial management system (CTMS). The software is an Office Business Application and is built on Microsoft Office SharePoint Server 2007. The product offers clinical trial study software that works with Microsoft Office, which eliminates redundancies of data entry and toggling between applications.
Office Smart Clinical Trial Manager
ClinBUS, a data interchange technology from TranSenda, creates a common data repository for a clinical trial's business process data. Leveraging open standards and CDISC conventions, ClinBUS addresses clinical data syntax and semantics and offers insight into metadata for dashboards, reports, and workflow.
TranSenda International, (866) 895-1300, www.transenda.com
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FOCUS Trial Results Show Solriamfetol Significantly Reduces ADHD Symptoms, Severity in Adults
March 27th 2025Solriamfetol achieved the primary and key secondary endpoint of the Phase III FOCUS trial by significantly lowering attention-deficit hyperactivity disorder symptoms and disease severity in adults compared to placebo, with a favorable safety and tolerability profile.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
